Gastrointestinal Drug Pellets

STABICOAT’s gastro-intestinal drug pellets are advanced multiparticulate dosage forms engineered for targeted drug delivery and controlled release within the gastrointestinal tract. These pellets are designed to achieve tailored release profiles such as enteric protection, sustained release, or site-specific absorption, thereby maximizing therapeutic efficacy. Developed through state-of-the-art coating technologies, they ensure resistance to gastric acid degradation while improving drug bioavailability. With uniform particle size distribution and high batch-to-batch reproducibility, they are well-suited for capsule filling & fixed-dose combination formulations. Manufactured under stringent GMP compliance, these pellets enable pharmaceutical companies worldwide to develop innovative, patient-friendly formulations with reduced capsule size & improved treatment outcomes.